İnce Başak, Phillips Matthew D, Zenasni Zohra, Shearer James, Dalton Bethan, Irish Madeleine, Mercado Daniela, Webb Hannah, McCombie Catherine, Au Katie, Kern Nikola, Clark-Stone Sam, Connan Frances, Johnston A Louise, Lazarova Stanimira, Zadeh Ewa, Newell Ciarán, Pathan Tayeem, Wales Jackie, Cashmore Rebecca, Marshall Sandra, Arcelus Jon, Robinson Paul, Byford Sarah, Landau Sabine, Lawrence Vanessa, Himmerich Hubertus, Treasure Janet, Schmidt Ulrike
Centre for Research in Eating and Weight Disorders (CREW), Department of Psychological Medicine, Institute of Psychiatry, Psychology, and Neuroscience, King's College London, London, UK.
Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology, and Neuroscience, King's College London, London, UK.
Eur Eat Disord Rev. 2024 May;32(3):476-489. doi: 10.1002/erv.3058. Epub 2023 Dec 18.
The relative merits of inpatient or day-treatment for adults with anorexia nervosa (AN) are unknown. The DAISIES trial aimed to establish the non-inferiority of a stepped-care day patient treatment (DPT) approach versus inpatient treatment as usual (IP-TAU) for improving body mass index (BMI) at 12 months in adults with AN. The trial was terminated due to poor recruitment. This paper presents outcomes and investigates the reasons behind the trial's failure.
Fifteen patients with AN (of 53 approached) participated and were followed-up to 6 or 12 months. Summary statistics were calculated due to low sample size, and qualitative data concerning treatment experiences were analysed using thematic analysis.
At baseline, participants in both trial arms rated stepped-care DPT as more acceptable. At 12 months, participants' BMIs had increased in both trial arms. Qualitative analysis highlighted valued and challenging aspects of care across settings. Only 6/12 sites opened for recruitment. Among patients approached, the most common reason for declining participation was their treatment preference (n = 12/38).
No conclusions can be drawn concerning the effectiveness of IP-TAU and stepped-care DPT, but the latter was perceived more positively. Patient-related, service-related and systemic factors (COVID-19) contributed to the trial's failure. Lessons learnt can inform future studies.
神经性厌食症(AN)成人患者接受住院治疗或日间治疗的相对优缺点尚不清楚。雏菊试验旨在确定一种逐步护理日间患者治疗(DPT)方法与常规住院治疗(IP-TAU)相比,在改善AN成人患者12个月时体重指数(BMI)方面的非劣效性。该试验因招募不佳而终止。本文介绍了试验结果并调查了试验失败的原因。
15名(共邀请了53名)AN患者参与并随访6或12个月。由于样本量小,计算了汇总统计数据,并使用主题分析对有关治疗经历的定性数据进行了分析。
在基线时,两个试验组的参与者都认为逐步护理DPT更可接受。在12个月时,两个试验组参与者的BMI均有所增加。定性分析突出了不同治疗环境中护理的重要方面和具有挑战性的方面。只有6/12个地点开放招募。在被邀请的患者中,拒绝参与的最常见原因是他们的治疗偏好(n = 12/38)。
关于IP-TAU和逐步护理DPT的有效性无法得出结论,但后者的看法更为积极。与患者相关、与服务相关和系统性因素(COVID-19)导致了试验失败。吸取的经验教训可为未来的研究提供参考。